Clinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Clinical trial NCT05768529 · RECRUITING
Trial details
- NCT number
- NCT05768529
- Sponsor
- Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-28
- Primary completion
- 2024-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.